|
To help migraineurs be heard, MAGNUM is working with DrugVoice, a company that takes the voices of patients directly to health care leaders, to improve treatment for all sufferers. DrugVoice has specifically created a survey - MigraineVoice - for migraineurs interested in sharing their voices. By completing the MigraineVoice survey, you will be able to communicate your personal experiences to the health care community. You will also have the opportunity to learn more about your disease and treatment alternatives and to compare your own experiences with those of other migraineurs. MAGNUM and DrugVoice are very committed to your privacy. Your individual responses to survey questions will remain private. |
|
|